Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

[18F]HTK-01174 shows promise for PET imaging of prostate cancer

Oct. 16, 2018

[18F]FC-303, an 18F-labeled PSMA radiotracer for PET imaging of prostate cancer

Oct. 16, 2018

Progenics plans phase II trial of 1095 for metastatic castration-resistant prostate cancer

Oct. 15, 2018

Progenics reports promising phase II/III data on PyL for detection of prostate cancer

Oct. 8, 2018

Patient recruitment ongoing in phase I/II study of imaging agent 89Zr-DFO-daratumumab

Oct. 8, 2018

Fluorescent virus-guided cytology detects active cancer cells in peritoneally disseminated GC

Oct. 5, 2018

Quinoline-based tracers targeting FAP show theranostic potential

Oct. 3, 2018

Optimized neuroimaging with fluorine-18-labeled SV2A PET tracers

Sep. 28, 2018

SGM-101 is safe and effective for intraoperative imaging of pancreatic ductal adenocarcinoma

Sep. 28, 2018

PET tracer for renal imaging tested in vivo

Sep. 21, 2018

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...